Abstract LB-016: Characteristics of the pretreatment tumor microenvironment may influence clinical response in patients with refractory large B cell lymphoma treated with axicabtagene ciloleucel (axi-cel) in the pivotal ZUMA-1
Year: 2018
Type: conference-abstract
Source: Cancer Research
Institutions: Inserm, Université Paris Descartes, Université Pierre-et-Marie-Curie, Moffitt Cancer Center, The University of Texas MD Anderson Cancer Center, Stanford Medicine, Stanford University, Dana-Farber Cancer Institute, University of Miami Health System, Sylvester Comprehensive Cancer Center, Mayo Clinic, Washington University in St. Louis
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2885439602